Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracycline”

355 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 355 results

Testing effectiveness (Phase 2)Ended earlyNCT00470249
What this trial is testing

Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Southampton 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT02993198
What this trial is testing

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

Who this might be right for
HER2 Positive Breast CancerCardiovascular Abnormalities
Northwestern University 134
Testing effectiveness (Phase 2)Study completedNCT00035126
What this trial is testing

EPO906 Therapy in Patients With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Looking for participantsNCT06045247
What this trial is testing

Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01446016
What this trial is testing

Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)

Who this might be right for
Breast NeoplasmsBreast Cancer
The Methodist Hospital Research Institute 38
Not applicableUnknownNCT02600442
What this trial is testing

Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

Who this might be right for
Breast NeoplasmsBreast Cancer
Assistance Publique - Hôpitaux de Paris 168
Testing effectiveness (Phase 2)Ended earlyNCT00955890
What this trial is testing

Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 12
Not applicableLooking for participantsNCT06898320
What this trial is testing

Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients

Who this might be right for
Heart InjuriesAnthracycline
IRCCS Burlo Garofolo 22
Large-scale testing (Phase 3)Study completedNCT00336791
What this trial is testing

Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 273
Not applicableNot Yet RecruitingNCT06881940
What this trial is testing

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Who this might be right for
Cancer Therapy-Related Cardiac Dysfunction
Instituto Nacional de Cardiologia Ignacio Chavez 284
Not applicableStudy completedNCT02916316
What this trial is testing

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Who this might be right for
LymphomaLarge B-CellDiffuse Large B-Cell
Fondazione Italiana Linfomi - ETS 127
Not applicableLooking for participantsNCT01790152
What this trial is testing

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Who this might be right for
Hodgkin Lymphoma in RemissionLeukemia in RemissionLymphoblastic Lymphoma+4 more
Children's Oncology Group 420
Post-approval studies (Phase 4)UnknownNCT04182568
What this trial is testing

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00439920
What this trial is testing

GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicableStudy completedNCT04036032
What this trial is testing

Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy

Who this might be right for
CancerCardiotoxicity
Connecticut Children's Medical Center 47
Large-scale testing (Phase 3)Study completedNCT00003070
What this trial is testing

Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer

Who this might be right for
Cardiac ToxicityUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 13
Testing effectiveness (Phase 2)Study completedNCT02685059
What this trial is testing

Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 174
Not applicableStudy completedNCT03964142
What this trial is testing

Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity

Who this might be right for
CardiotoxicityCardiac Rehabilitation
Hospital Clinico Universitario de Santiago 122
Testing effectiveness (Phase 2)UnknownNCT03890068
What this trial is testing

Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Sun Yat-sen University 48
Large-scale testing (Phase 3)Study completedNCT03265574
What this trial is testing

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Who this might be right for
Breast CancerNon Hodgkin Lymphoma
South Tees Hospitals NHS Foundation Trust 111
Load More Results